Your browser doesn't support javascript.
loading
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating ß-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu, Ruiqi; Li, Yuejin; Tian, Lantian; Shi, Huawen; Wang, Jiabei; Liang, Yingjian; Sun, Boshi; Wang, Shuangjia; Zhou, Meng; Wu, Li; Nie, Jianhua; Lin, Binlin; Tang, Shuli; Zhang, Yanqiao; Wang, Guangyu; Zhang, Chunhui; Han, Jiguang; Xu, Benjie; Liu, Lianxin; Gong, Kunmei; Zheng, Tongsen.
Afiliación
  • Liu R; Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou, China. Electronic address: liurq001@163.com.
  • Li Y; The First Department of General Surgery, First People's Hospital of Yunnan, Kunming, Yunnan Province, China. Electronic address: 851145521@qq.com.
  • Tian L; Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China. Electronic address: tianlantian99@163.com.
  • Shi H; Department of Gastrointestinal Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: haolianlian@126.com.
  • Wang J; Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, Heilongjiang Province, China. Electronic address: jiabeiwanghmu@126.com.
  • Liang Y; Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, Heilongjiang Province, China. Electronic address: liangyingjian_hyd@126.com.
  • Sun B; Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China. Electronic address: sunboshi12@126.com.
  • Wang S; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian Province, China. Electronic address: 214366663@qq.com.
  • Zhou M; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: zhoumenghmu@163.com.
  • Wu L; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: wulihmu@163.com.
  • Nie J; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: JianhuaNie1@163.com.
  • Lin B; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: 1822588466@qq.com.
  • Tang S; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: shuli_t@163.com.
  • Zhang Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: zhangyanqiao08@outlook.com.
  • Wang G; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: wgyhmu@163.com.
  • Zhang C; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: zhang_ch121@163.com.
  • Han J; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Heilongjiang Province, China. Electronic address: han_jg112@163.com.
  • Xu B; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China. Electronic address: 505361370@qq.com.
  • Liu L; Department of Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, Heilongjiang Province, China; Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key
  • Gong K; The First Department of General Surgery, First People's Hospital of Yunnan, Kunming, Yunnan Province, China. Electronic address: yuanyuanmiranda@hotmail.com.
  • Zheng T; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province, China; Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education),
Cancer Lett ; 443: 34-46, 2019 02 28.
Article en En | MEDLINE | ID: mdl-30503555
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Complejo de la Endopetidasa Proteasomal / Neoplasias Hepáticas Límite: Animals / Humans / Male Idioma: En Revista: Cancer Lett Año: 2019 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Complejo de la Endopetidasa Proteasomal / Neoplasias Hepáticas Límite: Animals / Humans / Male Idioma: En Revista: Cancer Lett Año: 2019 Tipo del documento: Article